Clinical outcomes after initialpseudomonasacquisition in cystic fibrosis

Standard care versus protocol based therapy for new onsetPseudomonas aeruginosain cystic fibrosis

(2013) Nicole Mayer-Hamblett et al.   PEDIATRIC PULMONOLOGY

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

(2012) Gerd Döring et al.   Journal of Cystic Fibrosis

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

(2012) Margaret Rosenfeld et al.   Journal of Cystic Fibrosis

Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis

(2011) Miriam M. Treggiari   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis

(2011) Nicole Mayer-Hamblett et al.   PEDIATRIC PULMONOLOGY

The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis

(2011) Reshma Amin et al.   PEDIATRIC PULMONOLOGY

Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

(2010) Don B. Sanders et al.   PEDIATRIC PULMONOLOGY

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,

(2009) Miriam M. Treggiari et al.   Contemporary Clinical Trials

Implementation of European standards of care for cystic fibrosis — Control and treatment of infection

(2009) J.S. Elborn et al.   Journal of Cystic Fibrosis

Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis

(2008) Wanda J. Kozlowska et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report

(2008) Philip M. Farrell et al.   JOURNAL OF PEDIATRICS